New Trends of Orally Disintegrating Tablet Market with Worldwide Industry Analysis to 2025

Drug delivery systems are becoming progressively sophisticated as pharmaceutical researchers obtain a good understanding of the biochemical and physiological parameters pertinent to their performance. The drug delivery through oral route is the standard technique in the pharmaceutical industry as it is considered as the most economic, convenient, and safest route of drug administration. The oral tablets are usually taken with water only with an exclusion of orally disintegrating tablets and chewing tablets. The oral tablets are released into the gastrointestinal tract and they are quickly absorbed into the blood circulation. Orally disintegrating tablet is a solid dosage form that quickly disintegrates or dissolves in the mouth within one minute and does not require water for swallowing.

Obtain Report Details: http://www.transparencymarketresearch.com/orally-disintegrating-tablet-market.html

Orally disintegrating tablets are becoming a choice of alternative for conventional tablets or capsules. The first orally disintegrating tablet was approved in 1996. Orally disintegrating tablets are known by many names such as fast dissolving, orodispersible, mouth-dissolving, and quick disintegrating tablets. They are uncoated tablets and they dispersed fast and are quickly absorbed. These tablets are intended to break down quickly in the mouth and the active pharmaceutical ingredients are absorbed in the gastrointestinal tract. They have been developed for various indications such as mental illness, migraine, and many other chronic medical conditions.

There are various methods available to develop orally disintegrating tablets such as tablet molding, freeze frying or lyophilization, spray drying, phase transition, mass-extrusion, cotton candy technology, direct compression method, and sublimation. The direct compression method is the most preferred method for manufacturing of orally disintegrating tablet as it provides adequate structural integrity and is cost effective in nature.

The global orally disintegrating tablet market is segmented on the basis of disease indication, distribution channel, and geography. On the basis of disease indication, the market is segmented into gastrointestinal diseases, central nervous system (CNS) diseases, oncology, and others. The CNS diseases segment is expected to gain high share of the market during the forecast period owing to increasing prevalence of CNS diseases such as depression, migraine, Parkinson’s disease, Alzheimer’s disease, and schizophrenia. Other than CNS diseases, the gastrointestinal diseases segment is expected to expand at a high CAGR during the forecast period. On the basis of distribution channel, the global market is segmented into hospital pharmacy, retail pharmacy, drug store, and online pharmacy.

Geographically, the global market for orally disintegrating tablet is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to register a high market share during the forecast period owing to increasing acceptance for technologically advanced products as well as rising prevalence of CNS diseases. Asia Pacific and Middle East & Africa are expected to expand at high CAGRs during the forecast period owing to low cost of orally disintegrating tablets and rise in awareness about various dosage form of tablet.

Tablets and capsules have certain limitations such as bitter taste, swallowing discomfort, and large size, especially for geriatric patients and children. These limitations of tablets and capsules are major driving factors for the orally disintegrating tablet market. In addition, rise in adoption of compliant dosage form and better taste have significantly increased the demand for orally disintegrating tablets, which is expected to drive the market growth during the forecast period.

However, there are hurdles in formulation of relatively high dose for orally disintegrating tablets. The difficulty level is high for the formulation of an orally disintegrating tablet with dose of 500 mg. Thus, the dose of a tablet is limited to 400 mg or less.

Key players operating in the global orally disintegrating tablet market include Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, AstraZeneca, GlaxoSmithKline plc, Johnson & Johnson Services, F. Hoffmann-La Roche Ltd., Johnson & Johnson Private Limited, Mission Pharmacal Company, and Sciele Pharma among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Smita Deshmukh is a veteran digital marketing professional, having worked for numerous online firms in his distinguished career. She believes in continuous learning, considering that the digital marketing sector’s rapidly evolving nature.

2022 Global Wireless Power Transmission Industry Market Size, Status, Share, Growth & Trends:Radiant Insights, Inc

This report studies the global Wireless Power Transmission market, analyzes and researches the Wireless Power Transmission development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

Qualcomm Technologies, Inc.
Texas Instruments Inc.
Leggett & Platt, Inc
Energizer Holdings, Inc.
Powermat Technologies Ltd.
PowerbyProxi Limited
Murata Manufacturing Co., Ltd
SAMSUNG ELECTRONICS Co., Ltd.
LG Electronics Inc.
WiTricity Corporation
Texzon Technologies, Ltd.
Mojo Mobility, Inc.

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Wireless Power Transmission can be split into
Inductive Coupling
Resonant Inductive Coupling
Capacitive Coupling
Others

Market segment by Application, Wireless Power Transmission can be split into
Consumer Electronics
Healthcare
Automotive
Industrial
Others

To Access Browse Full Research Report @:
http://www.radiantinsights.com/research/global-wireless-power-transmission-market-size-status-and-forecast-2022

Table of Contents

1 Industry Overview of Wireless Power Transmission
1.1 Wireless Power Transmission Market Overview
1.1.1 Wireless Power Transmission Product Scope
1.1.2 Market Status and Outlook
1.2 Global Wireless Power Transmission Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Wireless Power Transmission Market by Type
1.3.1 Inductive Coupling
1.3.2 Resonant Inductive Coupling
1.3.3 Capacitive Coupling
1.3.4 Others
1.4 Wireless Power Transmission Market by End Users/Application
1.4.1 Consumer Electronics
1.4.2 Healthcare
1.4.3 Automotive
1.4.4 Industrial
1.4.5 Others

About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.

Stevia Rebaudiana Extract Market 2022 – Industry Size, Share, Analysis, Trend & Future Strategic Planning

Stevia Rebaudiana Extract Market focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions such as Europe, North America, China, Japan, Southeast Asia and etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.

This report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

Major companies are as follows:

Tereos and PureCircle
Cargill
Evolva
GLG Life Tech
Biolotus Technology
Layn
Tate and Lyle
HuZhou LiuYin Biological
Hunan NutraMax Inc.
Tianjin Jianfeng

Major classifications are as follows:

0.5
0.6
0.8

Major applications are as follows:

Pharmaceutical
Food
Cosmetics

Major regions are as follows:

Europe
North America
China
Japan
Southeast Asia

Bharat Book is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

Cervical Cancer Vaccine Market: Industry Overview and Key Factors

Cancer in the cervix, which is the lower part of the uterus, is called cervical cancer. Its two primary types are squamous cells cancer and adenocarcinoma. 80% to 90%, i.e., a majority of cervical cancer cases fall under the former category. The latter is less common, constituting 10% to 20% of cases; however, the incidence of adenocarcinoma is rising predominantly in younger girls. Cervical cancer is a common type of cancer occurring in women worldwide. A major cause is infection by human papillomavirus (HPV) which is found in 99% of cervical cancer cases. HPV is sexually transmitted. Around 70% of cervical cancer cases could be attributed to infection caused by two major strains of virus, HPV-16 and HPV-18, which are also termed as high risk HPV types.

Obtain Report Details: http://www.transparencymarketresearch.com/cervical-cancer-vaccine-market.html

Cervical cancer can be prevented via widespread immunization with the HPV vaccine, which prevents infection from high-risk HPV strains and also offers protection against the low-risk ones which cause genital warts. The Center for Disease Control and Prevention (CDC) has recommended that the HPV vaccine be administered to girls and boys falling in the age group of 11 to 12 years old. Vaccination at an early stage of life, during teenage, is highly effective. In October 2016, the CDC updated the schedule of the HPV vaccination. It recommends that all teens and adolescents falling between the ages of 9 and 14 should receive two doses of HPV vaccination within a gap of six months.

The rising rate of cervical cancer among women is of particular concern as it is a significantly common type of cancer and a leading cause of death. Its increasing prevalence worldwide is a major driver for the cervical cancer vaccine market. The global surge in the number of cervical cancer patients, especially in developing countries, has motivated key players to develop new vaccines at a low cost. Most vaccines for cervical cancer are in their late stage of clinical development. The rising incidence of cervical cancer has provoked governments and non-profit organizations to take the initiative to create awareness regarding control & prevention of cervical cancer and HPV vaccinations. However, the high cost of the vaccine and the lack of awareness about HPV vaccination in developing countries are major restraining factors for the cervical cancer vaccine market.

The market can be segmented by vaccine type into the bivalent, quadrivalent, and 9-valent varieties. Currently, Gardasil, Gardasil 9, and Cervarix are the only three vaccines approved by the U.S. FDA and commercially available in market. Gardasil and Gardasil 9 are manufactured by Merck & Co., Inc. and Cervarix by GlaxoSmithKline plc. Gardasil is a quadrivalent vaccine which targets four different strains of HPV: HPV-6, HPV-11, HPV-16, and HPV-18.Cervarix is a bivalent vaccine targeting only two high-risk strains of HPV: HPV-16 and HPV-18.

Geographically, the global cervical cancer vaccine market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to hold a significant share in the market due to the rising prevalence of cervical cancer and awareness campaigns regarding HPV vaccination by the government and NGOs in the region. Alliances between the public and private sectors for the development of low-cost vaccines, favorable reimbursement policies, and high per capital income levels are also estimated to propel the market in North America. The high incidence of cervical cancer in developing countries and initiatives taken by WHO to develop affordable vaccines for prevention of cervical cancer in low- and middle-income countries are anticipated to drive the market in Asia Pacific, Latin America, and Africa.

Major players operating in the cervical cancer vaccine market include Merck & Co., Inc. and GlaxoSmithKline plc. Another prominent emerging player is ISA Pharmaceuticals B.V., whose immunotherapeutic vaccine is in its phase II trial of clinical development.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Smita Deshmukh is a veteran digital marketing professional, having worked for numerous online firms in his distinguished career. She believes in continuous learning, considering that the digital marketing sector’s rapidly evolving nature.

2022 Global Video Content Analysis(VCA) Industry Market Size, Status, Share, Growth & Trends:Radiant Insights, Inc

This report studies the global Video Content Analysis(VCA) market, analyzes and researches the Video Content Analysis(VCA) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

IBM
IntelliVision
Robert Bosch GmbH
Cisco Systems, Inc.
Honeywell International, Inc.
Axis Communications AB
Agent Video Intelligence, Inc.
Objectvideo, Inc.
Avigilon
Qognify
PureTech Systems
VCA Technology
DVTEL
ObjectVideo
Sony
Panasonic
PELCO
Honeywell Security
Siemens

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Video Content Analysis(VCA) can be split into
By Product Type
By Objects Type

Market segment by Application, Video Content Analysis(VCA) can be split into
BFSI Sector
Government Sector
Healthcare Sector
Industrial Sector
Retail Sector
Transport and Logistics sector

To Access Browse Full Research Report @:
http://www.radiantinsights.com/research/global-video-content-analysis-vca-market-size-status-and-forecast-2022

Table of Contents

1 Industry Overview of Video Content Analysis(VCA)

1.1 Video Content Analysis(VCA) Market Overview

1.1.1 Video Content Analysis(VCA) Product Scope

1.1.2 Market Status and Outlook

1.2 Global Video Content Analysis(VCA) Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Video Content Analysis(VCA) Market by Type

1.3.1 By Product Type

1.3.2 By Objects Type

1.4 Video Content Analysis(VCA) Market by End Users/Application

1.4.1 BFSI Sector

1.4.2 Government Sector

1.4.3 Healthcare Sector

1.4.4 Industrial Sector

1.4.5 Retail Sector

1.4.6 Transport and Logistics sector

About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.

mHealth Market to Project a CAGR of nearly 50% till 2020

mHealth Market

The global mHealth Market is poised to expand at a whopping CAGR nearly 50% over the forecast period (2012 to 2020). mHealth or mobile health involves the use of wireless devices and mobiles to offer healthcare services. Despite considerable developments in the field of healthcare services, there are a number of issues that still persist pertaining to affordability and availability. Penetration of smartphones with 4G and 3G networks owing to urbanization & high-income levels is expected to fuel the industry in the years to come.

3G & 4G LTE networks facilitate the prompt delivery of telemedicine services via speedy data transfers and video calls. High incidence of chronic diseases, such as diabetes, cancer, and heart ailments can contribute significantly to the global industry in the years to come. Various healthcare mobile applications may help patients in managing and controlling these ailments. However, infrastructural security and data privacy and safety may negatively impact overall demand during the forecast period.

Browse Details of Report @

https://www.hexaresearch.com/research-report/mhealth-industry

The worldwide mHealth market is segmented on the basis of services, participants, and geographies. According to services, the divisions are monitoring services, diagnosis services, healthcare systems strengthening services, and others. “Others” mainly pertains to wellness and prevention and thus focuses on geriatric care, smoking de-addiction, drug abuse prevention, healthy living, and child care. In 2013, monitoring services held more than 60% shares in the global market. Such services include independent aging solutions, post-acute care services, devices (body trackers) for monitoring vital signs, and chronic disease management. Diagnosis services facilitate effective communications between patients and healthcare professionals about various health related issues.

On the basis of participants, the industry is categorized into healthcare providers, content players, device vendors, and mobile operators. Being a rapidly expanding segment, mobile operators can continue dominating the global market over the forecast period. Beside connectivity services, they also offer end-to-end solutions, mobile telemedicine, content-based wellness information, and health call centers. This segment generates much of its revenues from monitoring & diagnostics services. Device vendors mainly refer to electronics & technology companies that offer equipment for gathering patient medical data and transmit data to back-end servers through mobile networks. Content players deal with information based services either through collaborations or in a stand-alone manner with mobile operators.

Geographically, the global mHealth market is segmented into Asia Pacific, North America, Europe, and Rest of the World. With a market share (in revenue terms) exceeding 30%, North America led the global industry in 2013. Regional drivers are surging demand for monitoring services because of growing prevalence of chronic diseases & ailments worldwide. Asia Pacific can expand robustly at a more than 45% CAGR over the forecast period. The region is fueled by growing need for better healthcare services.

Prominent companies operating in the global industry are Vodafone Group, Samsung Electronics, mQure, Orange, and Allscripts Healthcare Solutions among others. Kaiser Permanente and the Mayo Clinic’s venture capital unit supports an mHealth smoking cessation program that features an online communication & support platform and a wearable that releases drugs at equal time intervals. The concerned platform is undergoing clinical trials for both European and U.S. regulators. It may be available in the market in 2018 or 2019. Commonly known as the “Smartpatch”, this device releases biologically timed drugs. This action is based on the sensors that are present in the patch for measuring vital signs.

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Susan Hill is a Digital Marketer by professional and she has a great experience in blogging, content writing and SEO.

2022 Global Video Analysis(VA) Industry Market Size, Status, Share, Growth & Trends:Radiant Insights, Inc

This report studies the global Video Analysis(VA) market, analyzes and researches the Video Analysis(VA) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

IBM
IntelliVision
Robert Bosch GmbH
Cisco Systems, Inc.
Honeywell International, Inc.
Axis Communications AB
Agent Video Intelligence, Inc.
Objectvideo, Inc.
Avigilon
Qognify
PureTech Systems
VCA Technology
DVTEL
ObjectVideo
Sony
Panasonic
PELCO
Honeywell Security
Siemens

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Video Analysis(VA) can be split into
By Product Type
By Objects Type

Market segment by Application, Video Analysis(VA) can be split into
BFSI Sector
Government Sector
Healthcare Sector
Industrial Sector
Retail Sector
Transport and Logistics sector

To Access Browse Full Research Report @:
http://www.radiantinsights.com/research/global-video-analysis-va-market-size-status-and-forecast-2022

Table of Contents

1 Industry Overview of Video Analysis(VA)
1.1 Video Analysis(VA) Market Overview
1.1.1 Video Analysis(VA) Product Scope
1.1.2 Market Status and Outlook
1.2 Global Video Analysis(VA) Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Video Analysis(VA) Market by Type
1.3.1 By Product Type
1.3.2 By Objects Type
1.4 Video Analysis(VA) Market by End Users/Application
1.4.1 BFSI Sector
1.4.2 Government Sector
1.4.3 Healthcare Sector
1.4.4 Industrial Sector
1.4.5 Retail Sector
1.4.6 Transport and Logistics sector

About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements.

Tracheobronchial Stent Grafts Market is Growing at Significant Rate, 2025

Tracheobronchial stent grafts are used in management of lumen collapse or to prevent collapse after tracheobronchial reconstruction procedure, after trauma or lesions, airway obstruction etc. tracheobronchial stent-graft is a self-expanding stent generally made of nitinol mesh wire and encapsulated within two ultra-thin layers of expanded polytetrafluoroethylene (ePTFE). Moreover, number of benign and malignant conditions can cause tracheobronchial narrowing or collapse which can lead to symptomatic and life-threatening dyspnea. Tracheobronchial stent graft system is mainly approved for use in treatment of in-stent restenosis in venous outflow in hemodialysis patients. The first tracheobronchial stent graft system ‘Fluency’ was introduced in 2003 by C.R. Bard Inc. In 2005, W. L. Gore & Associates launched VIABAHN in the U.S. for use in treatment of tracheobronchial strictures. Both of these systems witnessed positive response from physicians and patients. Now-a-days, these devices are available in ling delivery sheaths or catheters necessary for placement of tracheobronchial stent graft.

Tracheobronchial Stent Grafts Market: Drivers and Restraints

Increasing prevalence of chronic lung disorders such as tuberculosis and benign or malignant tumors are the foremost factor driving the growth of global tracheobronchial stent grafts market over the forecast period. Besides, easy and efficient procedure is the other factor expected to flourish the global tracheobronchial stent grafts market However, limited product approvals for tracheobronchial stent grafts in Europe. And alternative treatment options for tracheobronchial strictures are the important factors limiting the growth of global tracheobronchial stent grafts market.

Tracheobronchial Stent Grafts Market: Overview

Recent approval of Fluency Plus brings new hope to patients suffering from chronic lung diseases that cause airway obstruction. These device is expected to gain rapid adoption by patients as it is minimally invasive procedure and involves less risk that other approaches used for management of tracheobronchial strictures. The global market for tracheobronchial stent grafts is expected to grow significantly with high single digit growth rate over the forecast period of 2017–2027.

Tracheobronchial Stent Grafts Market: Regional Outlook

Geographically, tracheobronchial stent grafts market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to dominate global tracheobronchial stent grafts market over the forecast period. Japan is expected to be the second largest market for tracheobronchial stent grafts. Despite the fact that tracheobronchial stent graft systems are being used since 2003, these systems are approved for clinical use only in the U.S., Canada and Japan. Key player in tracheobronchial stent grafts market is are trying to obtain regulatory approval in Europe in order to capture growing patient volume for chronic lung diseases.

A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/17002

Tracheobronchial Stent Grafts Market: Key Players

So far BARD Peripheral Vascular. Inc. – a subsidiary of C.R. Bard Inc., and W. L. Gore & Associates are the only player operating in the global market for tracheobronchial stent graft systems. Bard offers Fluency and Fluency Plus tracheobronchial stent grafts in North America and Japan. Some of the other systems such as Symbiot and Corvita Endoluminal Stent-Graft were being studied in the Europe but unfortunately they failed to meet required clinical end points and never came to market.

 

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

 

Contact Us

Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

Mahendra Lunkad is a Computer Engineer by education and a technology enthusiast by passion. He has a stint of experience in Blogging and SEO and loves to write.

Surgical Lasers Market by Product Type, Procedure, and Application – Global Industry Analysis and Forecast to 2025

Surgical Lasers Market Overview:

Laser surgeries are type of surgeries that are performed by using laser beam to make bloodless cuts in tissue or to remove different types of lesions such as skin lesions (Macule and Vesicle). Laser beams are strong beam of light produced by using either solid, liquid or gas materials. The laser beam is used to treat tissues by heating the cells until they burst; thereby destroying damaged and affected cells. On the basis of application or surgery and color of the tissue, different laser beams are used namely carbon dioxide lasers, YAG laser and pulse dye laser. Lasers are used to perform number of surgical procedures including breast surgery, hernia repair and treatment of pilonidal cyst. Lasers are increasingly use in large number of complex treatments with minimal blood loss, decreased patient comfort, decrease chances of infection and reduce extent of surgery. Moreover laser beams have high ability to penetrate tissue by adjusting wavelength of light which make them capable of use in range of medical problems.

Lasers are either used alone or with regular surgical instruments for restoring normal functioning of tissues and cells.  These lasers are increasingly used in surgical procedures with increase in demand for minimal invasive surgical procedures. Lasers are frequently used in lithotripsy, ophthalmology, and oncology, cosmetic and dermatological procedures. The unique ability of lasers to target specific cells and tissues made them a powerful tool in large number of aesthetic procedures. The specific wavelengths of laser beam induce soft tissue actions by penetrating in tissues to treat damaged skin without affecting surrounding undamaged skin. Aesthetic lasers technologies have changed the traditional methods available to dermatologist for getting rid of unwanted hairs, minimizing body scars, pores and acnes. Although lasers are single wavelength of light, they are capable of inducing strong improvements and changes in skin with relatively low time and complications.

High prevalence of chronic diseases, increasing geriatric population coupled with rise in ophthalmic disorders and rise in demand for minimal invasive surgeries is expected to propel growth of the market. According to World Health Organization in 2010, around 524 million people were aged 65 and above and this number is expected to triple and reach 1.5 billion by 2050. Between 2010 and 2050, the aging population in developing countries is expected to increase with more than 250 percent as compared to 71 percent increase in developed countries. Such high prevalence of elderly population will increase demand for surgical lasers. Furthermore, rapid technological advancements in the field of laser surgeries will fuel growth of the market in coming years. However, high cost of laser surgeries and limited reimbursement policies are expected to hamper growth of the surgical lasers market.

Some of the key players operating in the global market include Lumenis, Alma Lasers, Cynosure Inc., IPG Photonics Corporation, Spectranetics Corporation, Inc., Biolitec AG, and BISON MEDICAL .These players are focusing on either upgrading existing product or new product development to gain competitive edge over other players in the market leading to larger market share. For instance in September 2016, Alma Lasers has launched third generation platform known as LipoLife 3G which offers integrated platform for liposuction, skin grafting and tightening. LipoLife 3G is advanced liposuction technology with minimal bleeding and quick patient recovery time.

Emerging markets such as India, China and Brazil are expected to provide lucrative growth opportunities for market players owing to increasing demand for aesthetic procedures and increasing population base opting for laser surgeries. Moreover increasing preference for laser and aesthetics surgeries among male population will allow market players to capture large opportunities in this segment. According to study conducted by American Society of Plastic Surgeons in 2015, around 68,106 aesthetic breast reduction surgeries were performed in U.S. and men accounted for nearly 40% of breast reduction procedures. Such growing preference among male population will enhance overall surgical laser market.

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

I am very responsible person for prospecting for and securing advertisement sales for publications, including online magazines, trade journals, and Listing websites.

Optical Coherence Tomography (OCT) Market by Technology, Type, and Application – Global Industry Analysis and Forecast to 2025

Optical Coherence Tomography (OCT) Market Overview:

Optical coherence tomography is high resolution noninvasive imaging technology which is used to obtain cross sectional images of retina and optic nerve fibers. It uses light waves to produce high resolution 2D images of retina and related parts. Optical coherence tomography has evolved as one of the most important technology used in ophthalmic practices. Unique features offered by this technology enable broad range of research and clinical applications. This technology helps ophthalmologist to obtain images of distinctive layers of retina which helps in diagnosis of various eye disorders including age related macular degeneration and glaucoma. This technology employs light from range of light sources to obtain in-depth profile of retina.

There are two main methods of OCT-time domain (TD) and spectral domain (SD). Time domain optical coherence tomography uses broadband optical source and a photo detector. The principle of operation is based on partial coherence where photo detector senses variation in the interference to produce cross sectional images. Recent advancements in OCT technology have enabled imaging of nontransparent tissues by use of longer wavelength to reduce scattering of light across eye surface. One of the major applications of the technology is to use in conventional excisional biopsy by providing high depth images of pathology that cannot be obtained by use of other imaging techniques. Another important application of OCT is use in surgical interventions by enabling to see beneath the surface of tissues for surgical procedures of sensitive structures such as eye vessels and nerves. Although OCT technology is primarily used in ophthalmology, however owing to its unique property, OCT has found application in other fields such as dermatology and cardiology.

Increasing geriatric population is primary factor expected to propel growth of the global market. Elderly population is at high risk of developing chronic diseases and age related eye diseases including macular degeneration and cataract. Elderly population is rapidly growing owing to availability of advanced healthcare measures. According to World Health Organization in 2010, around 524 million people were aged 65 and above and this number is expected to triple and reach 1.5 billion by 2050. Between 2010 and 2050, the aging population in developing countries is expected to increase with more than 250 percent as compared to 71 percent increase in developed countries. Such high aging population base will increase demand for diagnostic technologies including optical coherence tomography. Furthermore, technological benefits offered by OCT such as ability to analyze in depth structure of eyes and related parts and extensive application of OCT in tissue imaging will further drive the growth of the market. However unfavorable reimbursement scenario and absence of sufficient clinical data is expected to hamper growth of the market.

Some of the players operating in global market include Agfa Healthcare, Carl Zeiss Meditec AG, Heidelberg Engineering GmbH, Imalux Corporation, Michelson Diagnostics, Novacam Technologies Inc., OPTOPOL Technology S.A., Topcon Medical Systems Inc., Thorlabs Inc and Optovue. These companies are focusing on expanding their product portfolio by launching new technologically advanced products to acquire larger market share on a global level. For instance in June 2016, Optovue had launched AngioVue Retina, an imaging system that provides ophthalmologist with dye-less and noninvasive way to visualize blood flow in the retina. AngioVue has retained essential features of OCT for quick visualization of retinal vessels which helps retina specialist to design treatment options for patients. Moreover major players are focusing on extensive marketing of their products to acquire large customer base leading to increased market share.

Technological advancements have rapidly revolutionized ophthalmic practices in last few years. Furthermore innovations in hardware and software technologies are expected to fuel growth of the market. Future trends like high speed imaging OCT techniques and use of longer wavelength options will provide growth opportunities for market players especially in emerging markets owing to rapidly increasing population with high prevalence of diseases and rise in demand for early detection techniques.

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

I am very responsible person for prospecting for and securing advertisement sales for publications, including online magazines, trade journals, and Listing websites.